The pharmaceutical and clinical research community is preparing to gather at the Sofitel Munich Bayerpost for the 11th annual Clinical Trials in Oncology Europe 2024 conference, a two-day event that promises to address critical challenges in oncology research and trial management.
AI Integration and Strategic Implementation
Frank Richard, vice president of Heidelburg, will kick off the conference with a crucial presentation on establishing AI strategies for oncology clinical trials. This session comes at a pivotal time when the industry is increasingly looking toward artificial intelligence to stabilize operations, particularly in trial recruitment. The presentation will outline key considerations for pharmaceutical companies planning to adopt AI technologies in their clinical research programs.
Addressing Patient Imaging Challenges
A significant portion of the conference will focus on reducing the burden of imaging procedures on trial participants. A panel featuring experts from Medidata and Dassault Systèmes, alongside patient advocates, will explore the complexities of imaging systems from the patient perspective. This discussion is particularly relevant given the global shortage of imaging specialists and radiologists, which often results in multiple specialist visits for trial participants.
Streamlining Clinical Processes
Daniela Duffet, senior solutions consultant at Suvoda, will present strategies for optimizing clinical processes to enhance patient experience. The presentation will highlight technological solutions designed to reduce site workloads and identify common patient stressors. This follows Suvoda's recent launch of a purpose-built software platform aimed at improving data management across trial sites.
Building Successful Biotech Companies
The conference will conclude with Node Pharma COO Helen Johansen's analysis of requirements for building successful biotechnology and pharmaceutical companies. This session will examine management techniques and address industry barriers in the post-pandemic landscape, where the life sciences sector has experienced significant restructuring through job cuts, mergers, and acquisitions.
The conference, scheduled for December 3-4, will bring together speakers from various organizations, including Sandoz and Blue Earth Therapeutics, offering a comprehensive view of current challenges and innovations in oncology clinical trials.
